Intellectual Property India Publishes Patent Application for 'Double-Stranded Dna Deaminases And Uses Thereof' Filed by New England Biolabs, Inc.

MUMBAI, India, July 5 -- Intellectual Property India has published a patent application (202517058841 A) filed by New England Biolabs, Inc., Ipswich, U.S.A., on June 19, for 'double-stranded dna deaminases and uses thereof.'

Inventor(s) include Sun, Zhiyi; Johnson, Sean, R.; Yan, Bo; Chen, Lixin; Robb, G., Brett; Evans, Thomas, C. Jr; and Vaisvila, Romualdas.

The application for the patent was published on July 4, under issue no. 27/2025.

According to the abstract released by the Intellectual Property India: "Provided herein, among other things, is a method for deaminating a double-stranded nucleic acid. In some embodiments, the method may comprise contacting a double-stranded DNA substrate that comprises cytosines and a double-stranded DNA deaminase having an amino acid sequence that is at least 80% identical to any of SEQ. ID NOS: 21, 40, 47, 49, 50, 55, 58, 59, 62, 63, 65, 67, 70, 71, 76, 106, 107, 110, 112, 114, 117, 163 and/or 164 to produce a deamination product that comprises deaminated cytosines. Enzymes and kits for performing the method are also provided."

The patent application was internationally filed on May 24, 2023, under International application No.PCT/US2023/067416.

Disclaimer: Curated by HT Syndication.